Advertisement
Australia markets closed

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • AUD/USD

    0.6413
    -0.0012 (-0.19%)
     

  • OIL

    83.90
    +1.17 (+1.41%)
     

  • GOLD

    2,400.10
    +2.10 (+0.09%)
     

  • Bitcoin AUD

    101,193.59
    +5,755.21 (+6.03%)
     

  • CMC Crypto 200

    1,315.65
    +3.03 (+0.23%)
     

  • AUD/EUR

    0.6022
    -0.0009 (-0.15%)
     

  • AUD/NZD

    1.0882
    +0.0007 (+0.07%)
     

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     

  • FTSE

    7,877.05
    0.00 (0.00%)
     

  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     

  • DAX

    17,837.40
    +67.38 (+0.38%)
     

  • Hang Seng

    16,237.60
    -148.27 (-0.90%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Why Crocs (CROX) Might be Well Poised for a Surge

Zacks Equity Research
·2-min read

Crocs (CROX) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.

The upward trend in estimate revisions for this footwear company reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Crocs, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

ADVERTISEMENT

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The earnings estimate of $0.12 per share for the current quarter represents a change of -78.18% from the number reported a year ago.

The Zacks Consensus Estimate for Crocs has increased 76.19% over the last 30 days, as one estimate has gone higher compared to no negative revisions.

Current-Year Estimate Revisions

For the full year, the earnings estimate of $0.85 per share represents a change of -47.2% from the year-ago number.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for Crocs. Over the past month, one estimate has moved higher compared to no negative revisions, helping the consensus estimate increase 14.29%.

Favorable Zacks Rank

The promising estimate revisions have helped Crocs earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

While strong estimate revisions for Crocs have attracted decent investments and pushed the stock 21.6% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Crocs, Inc. (CROX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research